124 related articles for article (PubMed ID: 38109851)
1. A potential cure for tumor-associated immunosuppression by Toxoplasma gondii.
Lotfalizadeh N; Sadr S; Morovati S; Lotfalizadeh M; Hajjafari A; Borji H
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1963. PubMed ID: 38109851
[TBL] [Abstract][Full Text] [Related]
2.
Chen J; Liao W; Peng H
Front Cell Infect Microbiol; 2022; 12():959300. PubMed ID: 36118042
[TBL] [Abstract][Full Text] [Related]
3. A uracil auxotroph Toxoplasma gondii exerting immunomodulation to inhibit breast cancer growth and metastasis.
Xu LQ; Yao LJ; Jiang D; Zhou LJ; Chen M; Liao WZ; Zou WH; Peng HJ
Parasit Vectors; 2021 Dec; 14(1):601. PubMed ID: 34895326
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.
Fox BA; Sanders KL; Chen S; Bzik DJ
Trends Parasitol; 2013 Sep; 29(9):431-7. PubMed ID: 23928100
[TBL] [Abstract][Full Text] [Related]
5. Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity.
Fox BA; Sanders KL; Rommereim LM; Guevara RB; Bzik DJ
PLoS Genet; 2016 Jul; 12(7):e1006189. PubMed ID: 27447180
[TBL] [Abstract][Full Text] [Related]
6. Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment.
Baird JR; Fox BA; Sanders KL; Lizotte PH; Cubillos-Ruiz JR; Scarlett UK; Rutkowski MR; Conejo-Garcia JR; Fiering S; Bzik DJ
Cancer Res; 2013 Jul; 73(13):3842-51. PubMed ID: 23704211
[TBL] [Abstract][Full Text] [Related]
7. Immune response against toxoplasmosis-some recent updates RH:
Sana M; Rashid M; Rashid I; Akbar H; Gomez-Marin JE; Dimier-Poisson I
Int J Immunopathol Pharmacol; 2022; 36():3946320221078436. PubMed ID: 35227108
[TBL] [Abstract][Full Text] [Related]
8. Improvement of a dendritic cell-based therapeutic cancer vaccine with components of Toxoplasma gondii.
Motamedi M; Arab S; Moazzeni SM; Khamis Abadi M; Hadjati J
Clin Vaccine Immunol; 2009 Oct; 16(10):1393-8. PubMed ID: 19656994
[TBL] [Abstract][Full Text] [Related]
9. Attenuated
Sanders KL; Fox BA; Bzik DJ
Oncoimmunology; 2016 Apr; 5(4):e1104447. PubMed ID: 27141388
[TBL] [Abstract][Full Text] [Related]
10.
Chen M; Yang P; Xin Z; Chen J; Zou W; Zhou L; Yang L; Peng J; Peng H
Front Immunol; 2023; 14():1173379. PubMed ID: 37426671
[No Abstract] [Full Text] [Related]
11. Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.
Chen J; Li ZY; Petersen E; Liu WG; Zhu XQ
Exp Parasitol; 2016 Mar; 162():18-23. PubMed ID: 26706605
[TBL] [Abstract][Full Text] [Related]
12. Secretory Microneme Proteins Induce T-Cell Recall Responses in Mice Chronically Infected with Toxoplasma gondii.
Saraav I; Wang Q; Brown KM; Sibley LD
mSphere; 2019 Feb; 4(1):. PubMed ID: 30814319
[TBL] [Abstract][Full Text] [Related]
13. Immediate Interferon Gamma Induction Determines Murine Host Compatibility Differences between Toxoplasma gondii and Neospora caninum.
Coombs RS; Blank ML; English ED; Adomako-Ankomah Y; Urama IS; Martin AT; Yarovinsky F; Boyle JP
Infect Immun; 2020 Mar; 88(4):. PubMed ID: 32014892
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of HLA-DR expression and antigen presentation in Toxoplasma gondii-infected melanoma cells by interleukin 6 and interferon gamma.
Yang TH; Aosai F; Norose K; Ueda M; Yano A
Microbiol Immunol; 1996; 40(6):443-9. PubMed ID: 8839430
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ production by brain-resident cells activates cerebral mRNA expression of a wide spectrum of molecules critical for both innate and T cell-mediated protective immunity to control reactivation of chronic infection with
Suzuki Y; Lutshumba J; Chen KC; Abdelaziz MH; Sa Q; Ochiai E
Front Cell Infect Microbiol; 2023; 13():1110508. PubMed ID: 36875520
[TBL] [Abstract][Full Text] [Related]
16. Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against toxoplasma gondii infection in mice.
Zhu YC; He Y; Liu JF; Chen J
Parasite; 2020; 27():26. PubMed ID: 32315596
[TBL] [Abstract][Full Text] [Related]
17. In vitro effect of TNF-alpha and IFN-gamma in retinal cell infection with Toxoplasma gondii.
Delair E; Creuzet C; Dupouy-Camet J; Roisin MP
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1754-60. PubMed ID: 19321794
[TBL] [Abstract][Full Text] [Related]
18. Nanocurcumin as an adjuvant in killed Toxoplasma gondii vaccine formulation: An experience in BALB/c mice.
Mahdi Ghahari SM; Ajami A; Sadeghizadeh M; Esmaeili Rastaghi AR; Mahdavi M
Exp Parasitol; 2022 Dec; 243():108404. PubMed ID: 36265591
[TBL] [Abstract][Full Text] [Related]
19. Novel Murine Pancreatic Tumor Model Demonstrates Immunotherapeutic Control of Tumor Progression by a Toxoplasma gondii Protein.
Payne SN; Emmerich PB; Davis NM; Deming DA; Knoll LJ
Infect Immun; 2021 Nov; 89(12):e0050821. PubMed ID: 34543124
[TBL] [Abstract][Full Text] [Related]
20. Immune response and protective effect against chronic Toxoplasma gondii infection induced by vaccination with a DNA vaccine encoding profilin.
Gao Q; Zhang NZ; Zhang FK; Wang M; Hu LY; Zhu XQ
BMC Infect Dis; 2018 Mar; 18(1):117. PubMed ID: 29514647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
